Counter-Generics Task Forces Deployed at 50% of Pharmaceutical Companies RESEARCH TRIANGLE PARK, NC--(Marketwire - February 24, 2010) -  Half of pharmaceutical companies deploy special task forces to plan for drugs' eventual patent expirations. Early results...